Image_12_Prostate cancer epidemiology and prognostic factors in the United States.tif by Saimaitikari Abudoubari (16893914)

“…Among the different age groups, the incidence rate was significantly increased in 15-54 and 55-64 age groups with AAPC of 4.03 (95% CI:2.73~5.34) and 2.50 (95% CI:0.96~4.05), respectively, and significantly decreased in ≥85 age group with AAPC of -2.50 (95% CI:-3.43~-1.57). …”

Image_7_Prostate cancer epidemiology and prognostic factors in the United States.tif by Saimaitikari Abudoubari (16893914)

“…Among the different age groups, the incidence rate was significantly increased in 15-54 and 55-64 age groups with AAPC of 4.03 (95% CI:2.73~5.34) and 2.50 (95% CI:0.96~4.05), respectively, and significantly decreased in ≥85 age group with AAPC of -2.50 (95% CI:-3.43~-1.57). …”

Image_3_Prostate cancer epidemiology and prognostic factors in the United States.tif by Saimaitikari Abudoubari (16893914)

“…Among the different age groups, the incidence rate was significantly increased in 15-54 and 55-64 age groups with AAPC of 4.03 (95% CI:2.73~5.34) and 2.50 (95% CI:0.96~4.05), respectively, and significantly decreased in ≥85 age group with AAPC of -2.50 (95% CI:-3.43~-1.57). …”

Image_11_Prostate cancer epidemiology and prognostic factors in the United States.tif by Saimaitikari Abudoubari (16893914)

“…Among the different age groups, the incidence rate was significantly increased in 15-54 and 55-64 age groups with AAPC of 4.03 (95% CI:2.73~5.34) and 2.50 (95% CI:0.96~4.05), respectively, and significantly decreased in ≥85 age group with AAPC of -2.50 (95% CI:-3.43~-1.57). …”

Image_4_Prostate cancer epidemiology and prognostic factors in the United States.tif by Saimaitikari Abudoubari (16893914)

“…Among the different age groups, the incidence rate was significantly increased in 15-54 and 55-64 age groups with AAPC of 4.03 (95% CI:2.73~5.34) and 2.50 (95% CI:0.96~4.05), respectively, and significantly decreased in ≥85 age group with AAPC of -2.50 (95% CI:-3.43~-1.57). …”

Image_2_Prostate cancer epidemiology and prognostic factors in the United States.tif by Saimaitikari Abudoubari (16893914)

“…Among the different age groups, the incidence rate was significantly increased in 15-54 and 55-64 age groups with AAPC of 4.03 (95% CI:2.73~5.34) and 2.50 (95% CI:0.96~4.05), respectively, and significantly decreased in ≥85 age group with AAPC of -2.50 (95% CI:-3.43~-1.57). …”

Table_1_Prostate cancer epidemiology and prognostic factors in the United States.docx by Saimaitikari Abudoubari (16893914)

“…Among the different age groups, the incidence rate was significantly increased in 15-54 and 55-64 age groups with AAPC of 4.03 (95% CI:2.73~5.34) and 2.50 (95% CI:0.96~4.05), respectively, and significantly decreased in ≥85 age group with AAPC of -2.50 (95% CI:-3.43~-1.57). …”

Image_8_Prostate cancer epidemiology and prognostic factors in the United States.tif by Saimaitikari Abudoubari (16893914)

“…Among the different age groups, the incidence rate was significantly increased in 15-54 and 55-64 age groups with AAPC of 4.03 (95% CI:2.73~5.34) and 2.50 (95% CI:0.96~4.05), respectively, and significantly decreased in ≥85 age group with AAPC of -2.50 (95% CI:-3.43~-1.57). …”

Table_1_Targeting immunosuppressive Ly6C+ classical monocytes reverses anti-PD-1/CTLA-4 immunotherapy resistance.xlsx by B. Leticia Rodriguez (1953484)

Image_10_Prostate cancer epidemiology and prognostic factors in the United States.tif by Saimaitikari Abudoubari (16893914)

“…Among the different age groups, the incidence rate was significantly increased in 15-54 and 55-64 age groups with AAPC of 4.03 (95% CI:2.73~5.34) and 2.50 (95% CI:0.96~4.05), respectively, and significantly decreased in ≥85 age group with AAPC of -2.50 (95% CI:-3.43~-1.57). …”

Presentation_1_Targeting immunosuppressive Ly6C+ classical monocytes reverses anti-PD-1/CTLA-4 immunotherapy resistance.pptx by B. Leticia Rodriguez (1953484)

Image_9_Prostate cancer epidemiology and prognostic factors in the United States.tif by Saimaitikari Abudoubari (16893914)

“…Among the different age groups, the incidence rate was significantly increased in 15-54 and 55-64 age groups with AAPC of 4.03 (95% CI:2.73~5.34) and 2.50 (95% CI:0.96~4.05), respectively, and significantly decreased in ≥85 age group with AAPC of -2.50 (95% CI:-3.43~-1.57). …”

Image_14_Prostate cancer epidemiology and prognostic factors in the United States.tif by Saimaitikari Abudoubari (16893914)

“…Among the different age groups, the incidence rate was significantly increased in 15-54 and 55-64 age groups with AAPC of 4.03 (95% CI:2.73~5.34) and 2.50 (95% CI:0.96~4.05), respectively, and significantly decreased in ≥85 age group with AAPC of -2.50 (95% CI:-3.43~-1.57). …”

Image_13_Prostate cancer epidemiology and prognostic factors in the United States.tif by Saimaitikari Abudoubari (16893914)

“…Among the different age groups, the incidence rate was significantly increased in 15-54 and 55-64 age groups with AAPC of 4.03 (95% CI:2.73~5.34) and 2.50 (95% CI:0.96~4.05), respectively, and significantly decreased in ≥85 age group with AAPC of -2.50 (95% CI:-3.43~-1.57). …”

Image_1_The Influence of Training Load on Hematological Athlete Biological Passport Variables in Elite Cyclists.TIFF by Tiffany Astolfi (10322177)

“…(Hb) averaged 14.2 ± 0.0 (mean ± SD) g^.dL⁻¹ (range: 13.3–15.5 g·dl⁻¹) over the study with significant changes over time (P = 0.004). …”

Image_7_The Influence of Training Load on Hematological Athlete Biological Passport Variables in Elite Cyclists.TIFF by Tiffany Astolfi (10322177)

“…(Hb) averaged 14.2 ± 0.0 (mean ± SD) g^.dL⁻¹ (range: 13.3–15.5 g·dl⁻¹) over the study with significant changes over time (P = 0.004). …”

Image_4_The Influence of Training Load on Hematological Athlete Biological Passport Variables in Elite Cyclists.TIFF by Tiffany Astolfi (10322177)

“…(Hb) averaged 14.2 ± 0.0 (mean ± SD) g^.dL⁻¹ (range: 13.3–15.5 g·dl⁻¹) over the study with significant changes over time (P = 0.004). …”

Data_Sheet_1_The Clinical Trial Outcomes of Med-Zenith PT-Valve in the Treatment of Patients With Severe Pulmonary Regurgitation.docx by Xiaoke Shang (3589976)

“…Post-procedural pulmonary artery diastolic pressure increased from 5.8 ± 3.1 to 11.3 ± 2.5 mmHg. In the 3-month and 1-year follow-up, the right ventricular end diastolic volume index reduced from the baseline 181.6 ± 29.0 to 143.7 ± 29.7 ml/m² and 123.4 ± 31.2 ml/m², and the trans-pulmonary valve gradient decreased from 25.6 ± 22.2 to 10.64 ± 3.54 mmHg and 11.16 ± 3.0 mmHg, respectively. …”

Image_6_The Influence of Training Load on Hematological Athlete Biological Passport Variables in Elite Cyclists.TIFF by Tiffany Astolfi (10322177)

“…(Hb) averaged 14.2 ± 0.0 (mean ± SD) g^.dL⁻¹ (range: 13.3–15.5 g·dl⁻¹) over the study with significant changes over time (P = 0.004). …”

Image_3_The Influence of Training Load on Hematological Athlete Biological Passport Variables in Elite Cyclists.TIFF by Tiffany Astolfi (10322177)

“…(Hb) averaged 14.2 ± 0.0 (mean ± SD) g^.dL⁻¹ (range: 13.3–15.5 g·dl⁻¹) over the study with significant changes over time (P = 0.004). …”